Company / Working Capital per Share
AbCellera Biologics Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.24
FY2025
5-year range
$2.24 / $3.20
FY2021-FY2025
Trend
-3.2%
vs FY2024
Sector context
#158 of 210
Health Care
What the data says
AbCellera Biologics Inc.'s working capital per share of $2.24 is lower than 75% of companies in the Health Care sector (FY2025). Working Capital per Share has declined for 3 consecutive years, from $3.20 in FY2022 to $2.24 in FY2025.
Based on SEC 10-K filings.
2.24 in FY2025 with a 5-year CAGR of -3.6%.
Declined from $2.62 to $2.24 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -11.2%
- 5-Year CAGR
- -3.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 210This company $2.24 Sector average $118.60
▼
-98.1% below sector average
Key checks
Key Insights
- AbCellera Biologics Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 3.2% year-over-year.
- Ranks #158 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.24 | -3.2% |
| FY2024 | $2.32 | -11.6% |
| FY2023 | $2.62 | -18.0% |
| FY2022 | $3.20 | +6.7% |
| FY2021 | $3.00 | +11.3% |
| FY2020 | $2.70 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026